XML 14 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Operations (unaudited) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Operating expense:    
Research & development $ 3,064,793 $ 1,077,846
General & administrative 7,094,832 450,210
Total operating expenses 10,159,625 1,528,056
Operating loss (10,159,625) (1,528,056)
Other (income) expense, net    
Interest (income) expense, net (99,368)
Total other (income) expense, net (99,368)
Net Loss $ (10,060,257) $ (1,528,056)
Weighted Average Shares Outstanding, basic and diluted 5,560,507 2,627,533
Net loss per share, basic and diluted $ (1.81) $ (0.58)